Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AbbVie, addicted, addiction, adequacy, amplification, anniversary, Antonio, apoptose, baseline, bioavailable, Biopharma, Boston, bought, Bulletin, Cantor, CASI, CF, cloud, CTI, cystic, Dana, depleted, Deposit, Diffuse, Digestive, discourage, DLBCL, Epidemiology, exome, Farber, FDIC, Fitzgerald, Geoffrey, Harvard, Herceptin, HR, investee, licensee, Los, lymphoma, MEI, MetaMax, MM, multilineage, MYC, MYCN, NCI, Nemucore, neuroblastoma, nonclinical, OfferingSM, oncogenic, orCF, OTC, OTCQB, overcome, palbociclib, Pharma, Pink, pituitary, profound, promulgated, propagate, provisional, quotation, rapid, regression, revealed, SA, San, Scheme, School, SEER, sequencing, Shapiro, simplify, stratification, Symposium, Synta, tiered, TNBC, today, transiently, triple, uterine, venetoclax, VSOE
Removed:
absence, acquired, activate, addressed, aggravated, aggregated, analyze, analyzed, APPRAISE, ASCO, assay, backup, Baxter, Belani, biopsy, blinded, Bonomi, Chandra, checkpoint, Chicago, concentrate, consultancy, contingency, controlling, correlation, coupled, Dacogen, declaration, detect, discontinuation, displayed, distinguishing, EGFR, Entremed, enzyme, escalating, excision, expansion, favoring, Fourteen, GMP, granulocyte, greatest, heavily, Hershey, Hospira, imaging, issuable, joint, killing, lacking, lineage, macrophage, Milton, mixed, modify, mutational, myelosuppression, myelotoxicity, nucleotide, observation, OS, overexpressing, Penn, PFS, Philip, placebo, placement, predictive, pretreated, ranging, recordkeeping, resensitized, retrospectively, reviewing, Rigel, Rush, safely, scenario, SE, settled, spectrum, staffing, strongly, suggesting, Tekmira, Topic, topline, transcription, transferred, unblinding, unexpected, unwilling, vested
Filing tables
Filing exhibits
Related press release
CYCC similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements (Nos. 333-205153, 333-183483, and 333-143786) on Form S-8 and (No. 333-187801) on Form S-3 of Cyclacel Pharmaceuticals, Inc. of our report dated March 29, 2016, relating to our audit of the consolidated financial statements, which appear in this Annual Report on Form 10-K of Cyclacel Pharmaceuticals, Inc. for the year ended December 31, 2015. On October 26, 2015, we changed the name of our firm from McGladrey LLP to RSM US LLP.
/s/ RSM US LLP
New York, New York
March 29, 2016
March 29, 2016